Our organizations collaborated to mobilize and dose the first patient with an investigational vaccination within 9 days of the outbreak. Moving to TAS. As you saw from our results, the business is recovering even better than we had forecasted. One area we continue to make great strides in is in building differentiating AI capabilities across our offerings. You will have seen we recently launched the IQVIA AI assistant, which is a new generative AI tool designed to provide life science customers with quick and powerful insights through a user-friendly conversational interface. This allows users to ask complex business questions and receive comprehensive and reliable answers in real time. IQVIA AI assistant is built on IQVIA's trademark health care-grade AI which enables extensive privacy safeguards and provides expert validation of accurate, reliable output as is demanded by the health care industry.